Mucosal colonisation with Lactobacillus casei mitigates barrier injury induced by exposure to trinitronbenzene sulphonic acid
Open Access
- 1 July 2005
- Vol. 54 (7) , 955-959
- https://doi.org/10.1136/gut.2004.056101
Abstract
Background: Trinitrobenzene sulphonic acid (TNBS) induces chronic transmural inflammatory lesions in the rat colon. Injury is facilitated by barrier disruption and invasion of commensal bacteria. However, certain bacteria have shown anti-inflammatory properties in in vitro models. Aim: To investigate in vivo the anti-inflammatory effect of Lactobacillus casei DN-114 001. Methods: Rats with a colonic segment excluded from faecal transit were surgically prepared. After washing the lumen with antibiotics, the excluded segment was recolonised (control group: standard flora of rat origin; test group: standard flora and L casei). Microbial colonisation was confirmed by culture of segment washing, and colitis was then induced by instillation of TNBS. One day after, intestinal lesions were blindly graded by macro- and microscopic scores, and myeloperoxidase activity measured in tissue homogenates. Translocation of bacteria to mesenteric lymph nodes, spleen and liver was investigated. Results: Test rats showed a smaller area of mucosal injury than control rats (pConclusion: In rats colonised with L casei, mucosal injury, inflammatory response, and barrier disruption after TNBS challenge were attenuated. Bacterial communities colonising the mucosa can modify inflammatory responses to luminal challenges.Keywords
This publication has 27 references indexed in Scilit:
- Lactobacilluscasei reduces CD8+ T cell‐mediated skin inflammationEuropean Journal of Immunology, 2004
- Lactic acid bacteria secrete metabolites retaining anti-inflammatory properties after intestinal transportGut, 2004
- Is the mucosal route of administration essential for probiotic function? Subcutaneous administration is associated with attenuation of murine colitis and arthritisGut, 2004
- Use of Mouse Models To Evaluate the Persistence, Safety, and Immune Modulation Capacities of Lactic Acid BacteriaClinical and Vaccine Immunology, 2003
- Modulation of colonic barrier function by the composition of the commensal flora in the ratGut, 2001
- Probiotic Therapy Fails to Improve Gut Permeability in a Hapten Model of ColitisScandinavian Journal of Gastroenterology, 2000
- Lactobacillus species prevents colitis in interleukin 10 gene–deficient miceGastroenterology, 1999
- Molecular association of trinitrobenzenesulfonic acid and surface phospholipids in the development of colitis in ratsGastroenterology, 1996
- Lactobacillus acidophilus LA 1 binds to cultured human intestinal cell lines and inhibits cell attachment and cell invasion by enterovirulent bacteria.Gut, 1994
- Guidelines on the recognition of pain, distress and discomfort in experimental animals and an hypothesis for assessmentVeterinary Record, 1985